Arthur S. Przybyl
2020
In 2020, Arthur S. Przybyl earned a total compensation of $857.8K as Former President and Chief Executive Officer at ANI Pharmaceuticals, a 85% decrease compared to previous year.
Compensation breakdown
| Salary | $332,847 |
|---|---|
| Other | $524,967 |
| Total | $857,814 |
Przybyl received $525K in other compensation, accounting for 61% of the total pay in 2020.
Przybyl also received $332.8K in salary.
Rankings
In 2020, Arthur S. Przybyl's compensation ranked 9,225th out of 13,090 executives tracked by ExecPay. In other words, Przybyl earned more than 29.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,225 out of 13,090 | 30th |
Division Manufacturing | 3,941 out of 5,621 | 30th |
Major group Chemicals And Allied Products | 1,602 out of 2,254 | 29th |
Industry group Drugs | 1,401 out of 1,954 | 28th |
Industry Pharmaceutical Preparations | 1,026 out of 1,459 | 30th |
Source: SEC filing on April 29, 2021.
Przybyl's colleagues
We found five more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2020.
2020
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
2020
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
2020
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
2020
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
2020
Patrick Walsh
ANI Pharmaceuticals